Cover Image
市場調查報告書

美國的心血管介入設備市場預測

United States Interventional Cardiology Market Outlook to 2021

出版商 GlobalData 商品編碼 304751
出版日期 內容資訊 英文 172 Pages
訂單完成後即時交付
價格
Back to Top
美國的心血管介入設備市場預測 United States Interventional Cardiology Market Outlook to 2021
出版日期: 2016年02月01日 內容資訊: 英文 172 Pages
簡介

本報告提供美國的心血管介入設備市場相關資料,提供動脈切開、密合設備,心導管,冠狀動脈用導管導引線,冠狀動脈支架,血管內超音波檢查裝置(IVUS),PTCA球囊擴張術及PTCA冠狀動脈藥物釋放型球囊(DEB)等各類別銷售額,銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再彙整主要企業簡介,開發中產品,主要的財務相關交易等最新資訊。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 心血管介入設備市場區分
  • 該報告對象市場定義

第3章 美國的心血管介入設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic, Inc.
  • Cordis Corporation
  • Terumo Corporation
  • Volcano Corporation
  • St. Jude Medical, Inc.

第5章 開發中產品

第6章 財務交易情勢

  • 收購
  • 資本交易
  • 發行公司債券
  • 合併
  • 聯盟
  • 創業融資

第7章 最新趨勢

  • 企業通訊
  • 財務發表
  • 政府·公益相關
  • 法律規章
  • 其他的重要趨勢
  • 產品資訊
  • 研究開發
  • 策略及產業規劃

第8章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC1433DB

GlobalData's new report, "United States Interventional Cardiology Market Outlook to 2021", provides key market data on the United States Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Interventional Cardiology market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons and PTCA Drug Eluting Balloon (DEB) Catheters.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Interventional Cardiology market.
  • Global corporate-level profiles of key companies operating within the United States Interventional Cardiology market.
  • Key players covered include Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cordis Corporation, Terumo Corporation and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Interventional Cardiology Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Interventional Cardiology Market, United States

  • 3.1. Interventional Cardiology Market, United States, Revenue ($m), 2007-2014
  • 3.2. Interventional Cardiology Market, United States, Revenue ($m), 2014-2021
    • 3.2.1. Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Coronary Stents Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.4. Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.5. PTCA Balloons Market, United States, Revenue ($m), by Segment, 2007-2014
    • 3.2.6. Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.7. Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.8. Coronary Stents Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.9. Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2014-2021
    • 3.2.10. PTCA Balloons Market, United States, Revenue ($m), by Segment, 2014-2021
  • 3.3. Interventional Cardiology Market, United States, Volume (Units), 2007-2014
  • 3.4. Interventional Cardiology Market, United States, Volume (Units), 2014-2021
    • 3.4.1. Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Cardiac Catheters Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Coronary Stents Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.4. Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.5. PTCA Balloons Market, United States, Volume (Units), by Segment, 2007-2014
    • 3.4.6. Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.7. Cardiac Catheters Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.8. Coronary Stents Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.9. Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2014-2021
    • 3.4.10. PTCA Balloons Market, United States, Volume (Units), by Segment, 2014-2021
  • 3.5. Interventional Cardiology Market, United States, Average Price ($), 2007-2021
  • 3.6. Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in United States, Interventional Cardiology Market

  • 4.1. Boston Scientific Corporation
    • 4.1.1. Company Overview
  • 4.2. Abbott Laboratories
    • 4.2.1. Company Overview
  • 4.3. Medtronic plc
    • 4.3.1. Company Overview
  • 4.4. St. Jude Medical, Inc.
    • 4.4.1. Company Overview
  • 4.5. Asahi Intecc Co., Ltd.
    • 4.5.1. Company Overview
  • 4.6. Volcano Corporation
    • 4.6.1. Company Overview
  • 4.7. Cook Medical Incorporated
    • 4.7.1. Company Overview
  • 4.8. Terumo Corporation
    • 4.8.1. Company Overview
  • 4.9. Edwards Lifesciences Corporation
    • 4.9.1. Company Overview
  • 4.10. Cordis Corporation
    • 4.10.1. Company Overview
  • 4.11. Cardinal Health, Inc.
    • 4.11.1. Company Overview

5. Interventional Cardiology Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Acquisition
    • 6.1.1. AtriCure Acquires nContact
    • 6.1.2. TE Connectivity Acquires AdvancedCath for USD190 Million
  • 6.2. Debt Offerings
    • 6.2.1. Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020
  • 6.3. Equity Offerings
    • 6.3.1. Hansen Medical to Raise USD35 Million in Private Placement of Shares and Warrants
    • 6.3.2. Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants
  • 6.4. Venture Financing
    • 6.4.1. Saphena Medical Raises USD1.27 Million in Venture Financing
    • 6.4.2. Cardiac Dimensions Raises Additional USD15.2 Million in Venture Financing
    • 6.4.3. Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round

7. Recent Developments

  • 7.1. Corporate Communications
    • 7.1.1. Dec 22, 2015: SurModics Announces Device Veteran Shawn McCormick Joins Board of Directors
    • 7.1.2. Dec 15, 2015: Cardiac Dimensions Announces Appointment Of Gregory D. Casciaro As President And Chief Executive Officer
    • 7.1.3. Nov 09, 2015: AngioDynamics Announces Resignation of CFO and Appointment of Interim CFO
    • 7.1.4. Nov 02, 2015: Data from Merz Aesthetics' Post-Market Clinical Study of Xeomin(incobotulinumtoxinA) vs. Botox (onabotulinumtoxinA) for Glabellar Facial Lines Published in Dermatologic Surgery
    • 7.1.5. Oct 08, 2015: SANUWAVE Health Releases dermaPACE Clinical Trial Top Line Data and Preliminary Data Analysis Results
    • 7.1.6. Sep 09, 2015: LED Medical Diagnostics' VELscope Vx Receives Regulatory Approval for Distribution in China
    • 7.1.7. Aug 10, 2015: Transgenomic Establishes Clinical-Commercial Advisory Board to Help Optimize Use of Multiplexed ICE COLD-PCR in Oncology
    • 7.1.8. Jul 15, 2015: Boston Scientific Elects Donna A. James To Board Of Directors
    • 7.1.9. Jun 25, 2015: Medtronic Names Geoff Martha Executive Vice President and President, Restorative Therapies Group
    • 7.1.10. Jun 09, 2015: Transgenomic Expands Board of Directors and Executive Team
    • 7.1.11. May 27, 2015: Boston Scientific Names Prof. John Mark Morgan as Senior Medical Director, Rhythm Management
    • 7.1.12. May 26, 2015: IMRIS and Two Subsidiaries File for Chapter 11 Protection
    • 7.1.13. Apr 13, 2015: Onxeo announces 6th positive DSMB recommendation for Livatag ReLive study in HCC
    • 7.1.14. Mar 06, 2015: SurModics Announces New Board Chair
    • 7.1.15. Mar 03, 2015: Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors
    • 7.1.16. Feb 24, 2015: Cardiva Medical Announces Appointment of John Russell, President and Chief Executive Officer
    • 7.1.17. Feb 05, 2015: SurModics Announces Gerald B. Fischer's Retirement from Board of Directors
  • 7.2. Financial Announcements
    • 7.2.1. Dec 18, 2015: BRILIQUE (ticagrelor) receives positive European Union CHMP opinion for extended treatment of patients with a history of heart attack
    • 7.2.2. Dec 18, 2015: Sarepta Therapeutics Announces FDA Advisory Committee Meeting to Review Eteplirsen as a Treatment for Duchenne Muscular Dystrophy Amenable to Exon 51. Skipping
    • 7.2.3. Nov 12, 2015: Transgenomic Reports Third Quarter 2015 Financial Results
    • 7.2.4. Nov 10, 2015: SurModics Reports Fourth Quarter Fiscal 2015 Results
    • 7.2.5. Nov 05, 2015: Hansen Medical Reports Third Quarter 2015 Results and Business Update
    • 7.2.6. Oct 28, 2015: Boston Scientific Announces Results For Third Quarter 2015
    • 7.2.7. Oct 08, 2015: AngioDynamics to Present at the Jefferies 2015 Healthcare Conference
    • 7.2.8. Oct 01, 2015: FDA Panel To Discuss On TransMedics PMA Application For OCS Heart Device
    • 7.2.9. Sep 30, 2015: MediWound Awarded BARDA Contract Valued Up to $112 Million for Development and Procurement of NexoBrid for the U.S.
    • 7.2.10. Sep 09, 2015: Tandem Diabetes Care Announces FDA Approval of t:slim G4 Insulin Pump with CGM Integration
    • 7.2.11. Aug 13, 2015: Transgenomic Reports Second Quarter 2015 Financial Results
    • 7.2.12. Aug 06, 2015: Hansen Medical Reports Second Quarter 2015 Results and Business Update
    • 7.2.13. Aug 05, 2015: SurModics Reports Third Quarter Fiscal 2015 Results
    • 7.2.14. Jul 23, 2015: Boston Scientific Announces Results For Second Quarter 2015
    • 7.2.15. Jul 16, 2015: AngioDynamics Reports Fiscal 2015 Fourth Quarter and Full Year Financial Results
    • 7.2.16. Jul 01, 2015: Aesculap Implant Systems Introduces the Modulift Vertebral Body Replacement System
    • 7.2.17. Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results
    • 7.2.18. May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results
    • 7.2.19. May 14, 2015: Transgenomic Reports First Quarter 2015 Financial Results
    • 7.2.20. May 07, 2015: Hansen Medical Reports First Quarter 2015 Results and Business Update
    • 7.2.21. Apr 30, 2015: SurModics Reports Second Quarter Fiscal 2015 Results
    • 7.2.22. Apr 28, 2015: Boston Scientific Announces Results for First Quarter 2015
    • 7.2.23. Apr 15, 2015: Transgenomic Provides Financial and Business Update
    • 7.2.24. Apr 09, 2015: AngioDynamics Reports 2015 Third Quarter Financial Results
    • 7.2.25. Mar 04, 2015: IMRIS Reports Fourth Quarter and Annual 2014 Financial Results
    • 7.2.26. Feb 23, 2015: Hansen Medical Reports Fourth Quarter and Full-Year 2014 Results
    • 7.2.27. Feb 04, 2015: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2014
    • 7.2.28. Jan 29, 2015: SurModics Reports First Quarter Fiscal 2015 Results
    • 7.2.29. Jan 13, 2015: European Medicines Agency Grants Positive Opinion for Orphan Drug Status for Ovarian Cancer Oncolytic Vaccine
  • 7.3. Legal And Regulatory
    • 7.3.1. Dec 03, 2015: FDA Lifts Warning Letters on AngioDynamics' Facilities
    • 7.3.2. Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury's Notice 2015-79
    • 7.3.3. Nov 17, 2015: AngioDynamics Announces Resolution of FDA Warning Letter
    • 7.3.4. Aug 20, 2015: Harvard's Wyss Institute improves its sepsis therapeutic device
    • 7.3.5. Apr 02, 2015: Medtronic To Pay $4.41 Million To Resolve Allegations That It Unlawfully Sold Medical Devices Manufactured Overseas
    • 7.3.6. Feb 17, 2015: Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation
    • 7.3.7. Feb 06, 2015: Medtronic to Pay $2.8 Million to Resolve False Claims Act Allegations Related to "SubQ Stimulation" Procedures
    • 7.3.8. Feb 04, 2015: Federal judge approves consent decree with Maquet Holding
  • 7.4. Other Significant Developments
    • 7.4.1. Jan 08, 2016: SurModics Provides Updated 2016 Guidance
    • 7.4.2. Oct 15, 2015: New Swedish clinic treats first cancer patients with proton therapy
    • 7.4.3. May 06, 2015: Boston Scientific Coyol, Costa Rica Facility Earns Shingo Award For Excellence In Manufacturing
    • 7.4.4. May 01, 2015: Boston Scientific Outlines Growth And Expansion Strategy At 2015 Investor Day
    • 7.4.5. Feb 10, 2015: Premier awards specialty urology purchasing contract to Cook Medical
    • 7.4.6. Feb 03, 2015: Boston Scientific Maple Grove Operations Named A 2014 "Best Plants" Winner
    • 7.4.7. Jan 12, 2015: Medtronic Awards $150,000 Locally in Health Access Grants

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 6: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 8: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 9: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 10: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 12: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 13: Interventional Cardiology Market, United States, Volume (Units), Historic, 2007-2014
  • Table 14: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 15: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Table 16: Cardiac Catheters Market, United States, Volume (Units), Historic, 2007-2014
  • Table 17: Coronary Stents Market, United States, Volume (Units), Historic, 2007-2014
  • Table 18: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2007-2014
  • Table 19: PTCA Balloons Market, United States, Volume (Units), Historic, 2007-2014
  • Table 20: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 21: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 22: Coronary Stents Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 23: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 24: PTCA Balloons Market, United States, Volume (Units), Forecast, 2014-2021
  • Table 25: Interventional Cardiology Market, United States, Average Price ($) Historic, 2007-2014
  • Table 26: Interventional Cardiology Market, United States, Average Price ($), Forecast, 2014-2021
  • Table 27: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 28: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2014
  • Table 29: Interventional Cardiology Market Pipeline Products
  • Table 30: AtriCure Acquires nContact
  • Table 31: TE Connectivity Acquires AdvancedCath for USD190 Million
  • Table 32: Boston Scientific Raises USD600 Million in Public Offering of 2.850% Notes Due 2020
  • Table 33: Hansen Medical to Raise USD35 Million in Private Placement of Shares and Warrants
  • Table 34: Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants
  • Table 35: Saphena Medical Raises USD1.27 Million in Venture Financing
  • Table 36: Cardiac Dimensions Raises Additional USD15.2 Million in Venture Financing
  • Table 37: Apama Medical Raises USD11 Million in First Tranche of Series B Venture Financing Round
  • Table 38: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures

  • Figure 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Coronary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 6: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 8: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 9: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 10: Coronary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 12: PTCA Balloons Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Interventional Cardiology Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 14: Interventional Cardiology Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 15: Arteriotomy Closure Devices Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 16: Cardiac Catheters Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 17: Coronary Stents Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 18: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 19: PTCA Balloons Market, United States, Volume (Units), Historic, 2007-2014
  • Figure 20: Arteriotomy Closure Devices Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 21: Cardiac Catheters Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 22: Coronary Stents Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 23: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 24: PTCA Balloons Market, United States, Volume (Units), Forecast, 2014-2021
  • Figure 25: Interventional Cardiology Market, United States, Company Share (%) 2014
  • Figure 26: GlobalData Epidemiology-Based Forecasting Model
  • Figure 27: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 28: Primary Interviews by Participant Type (%)
Back to Top